2024 Conference Coverage
Playback speed
10 seconds
Long-Term (Up to 6 Years) Efficacy of Ofatumumab in People With Recently Diagnosed and Treatment-Naive Relapsing Multiple Sclerosis
94 views
May 3, 2024
Login to view comments.
Click here to Login